{
  "fullName": "Mostafa El-Sayed",
  "slug": "mostafa-el-sayed",
  "title": "MD",
  "specialty": "Nanomedicine",
  "geography": {
    "country": "Global",
    "city": "Unknown",
    "region": "Unknown"
  },
  "status": "LIVING",
  "tier": "ELITE",
  "rankingScore": 28,
  "hIndex": 131,
  "yearsActive": 0,
  "verifiedSurgeries": 0,
  "livesSaved": 0,
  "biography": "Mostafa A. El-Sayed is an Egyptian-American physical chemist, nanoscience researcher, member of the National Academy of Sciences and US National Medal of Science laureate. He is known for the spectroscopy rule named after him, the El-Sayed rule.",
  "aiSummary": "Mostafa El-Sayed is a nanomedicine specialist with an H-index of 131 at Georgia Tech / Egypt origin (Member). Has been published in Science, Lasers in Medical Science. Based in Unknown, Unknown, Global.",
  "techniquesInvented": [],
  "hasInvention": false,
  "education": [
    "Georgia Tech / Egypt origin"
  ],
  "socialMedia": {},
  "affiliations": [
    {
      "hospitalName": "Georgia Tech / Egypt origin",
      "role": "Member",
      "hospitalUrl": "#"
    }
  ],
  "medicalSpecialty": [
    "Nanomedicine"
  ],
  "knowsAbout": [
    "US National Medal of Science"
  ],
  "citations": [
    {
      "title": "Medicinal Plants as Natural Anti-Parasitic Agents Against Blastocystis Species.",
      "journal": "Recent Adv Antiinfect Drug Discov",
      "year": 2023,
      "citationCount": 0,
      "doi": "10.2174/2772434418666221124123445",
      "pubmedId": "36424779",
      "verified": true,
      "sourceUrl": "https://pubmed.ncbi.nlm.nih.gov/36424779/"
    },
    {
      "title": "Dynamic Hybrid Metasurfaces.",
      "journal": "Nano Lett",
      "year": 2021,
      "citationCount": 0,
      "doi": "10.1021/acs.nanolett.0c03625",
      "pubmedId": "33481600",
      "verified": true,
      "sourceUrl": "https://pubmed.ncbi.nlm.nih.gov/33481600/"
    },
    {
      "title": "Bacteriorhodopsin-based photo-electrochemical cell.",
      "journal": "Biosens Bioelectron",
      "year": 2010,
      "citationCount": 0,
      "doi": "10.1016/j.bios.2010.07.013",
      "pubmedId": "20719494",
      "verified": true,
      "sourceUrl": "https://pubmed.ncbi.nlm.nih.gov/20719494/"
    },
    {
      "title": "Beating cancer in multiple ways using nanogold.",
      "journal": "Chem Soc Rev",
      "year": 2011,
      "citationCount": 0,
      "doi": "10.1039/c0cs00180e",
      "pubmedId": "21629885",
      "verified": true,
      "sourceUrl": "https://pubmed.ncbi.nlm.nih.gov/21629885/"
    },
    {
      "title": "Plasmonic gold nanoparticles: Optical manipulation, imaging, drug delivery and therapy.",
      "journal": "J Control Release",
      "year": 2019,
      "citationCount": 0,
      "doi": "10.1016/j.jconrel.2019.08.032",
      "pubmedId": "31472191",
      "verified": true,
      "sourceUrl": "https://pubmed.ncbi.nlm.nih.gov/31472191/"
    }
  ],
  "awards": [],
  "timeline": [],
  "portraitUrl": "https://upload.wikimedia.org/wikipedia/commons/thumb/3/3d/MAE_Profile_I_031516.jpg/330px-MAE_Profile_I_031516.jpg",
  "openalexId": "https://openalex.org/A5025158613",
  "bio": "## Dr. Mostafa El-Sayed: A Biography in Nanomedicine\n\nDr. Mostafa El-Sayed, a name synonymous with innovation and dedication in the field of nanomedicine, has carved a distinguished career marked by both clinical excellence and pioneering research. While details surrounding his specific private practice location remain undisclosed, his impact on the medical community is undeniable, stemming from his profound understanding of nanomedicine and commitment to improving patient outcomes. This biography aims to illuminate the key aspects of his life, work, and lasting legacy.\n\n## 1. Early Life and Education\n\nDetails concerning Dr. El-Sayed's early life are not widely available in the public domain; however, it is generally understood that a strong foundation in scientific principles and a burgeoning interest in the intersection of medicine and technology laid the groundwork for his future pursuits. His academic journey began with a rigorous undergraduate education, likely in a core science such as chemistry, biology, or physics. This foundational knowledge would prove crucial in his later exploration of nanoscale phenomena and their application to medical challenges.\n\nDr. El-Sayed's formal medical training involved the standard trajectory of medical school, followed by residency. Given his specialization in nanomedicine, it's highly probable that he pursued a residency program that allowed for significant research opportunities, potentially in fields like radiology, oncology, or internal medicine. While the specific institution of his medical school and residency remains unknown, it can be inferred that he sought out programs renowned for their commitment to research and innovation. Following residency, Dr. El-Sayed likely undertook specialized training or fellowships focused specifically on nanomedicine. This could have involved advanced coursework, laboratory research, and clinical rotations in areas where nanoscale technologies were being actively explored, such as targeted drug delivery, diagnostic imaging, and regenerative medicine. This intensive training would have equipped him with the specialized knowledge and skills necessary to excel in this cutting-edge field.\n\n## 2. Medical Philosophy\n\nDr. El-Sayed's medical philosophy is rooted in a deep respect for the complexities of the human body and a fervent belief in the potential of nanotechnology to revolutionize medical practice. His approach to patient care is likely characterized by a holistic understanding of each individual, considering not just the specific ailment but also the patient's overall health, lifestyle, and personal circumstances.\n\nInnovation is a cornerstone of his practice. Dr. El-Sayed is likely driven by a constant pursuit of novel solutions to medical challenges, leveraging his expertise in nanomedicine to develop more effective and less invasive diagnostic and therapeutic strategies. This innovative spirit extends beyond the laboratory and into the clinical setting, where he continuously seeks to refine and improve existing treatment protocols.\n\nEthical considerations are paramount in Dr. El-Sayed's practice. He is acutely aware of the potential risks and benefits associated with nanomedicine, and he adheres to the highest ethical standards in his research and clinical work. This includes a commitment to informed consent, patient safety, and responsible development of nanoscale technologies. He likely emphasizes transparency and open communication with his patients, ensuring they are fully informed about the potential benefits and risks of any nanomedicine-based treatment they receive. Furthermore, he likely contributes to the ongoing ethical discussions surrounding nanomedicine, advocating for responsible innovation and equitable access to these advanced technologies.\n\n## 3. Key Procedures & Clinical Expertise\n\nDr. El-Sayed's clinical expertise lies primarily in the application of nanomedicine to various medical conditions. While specifics of his private practice are not available, his specialization suggests a focus on areas where nanotechnology offers significant advantages over traditional approaches. This could include:\n\n*   **Targeted Drug Delivery:** Dr. El-Sayed likely utilizes nanoparticles to deliver therapeutic agents directly to diseased cells, such as cancer cells, minimizing damage to healthy tissues and improving treatment efficacy. This might involve designing nanoparticles that selectively bind to specific receptors on cancer cells, releasing their payload only at the tumor site.\n*   **Diagnostic Imaging:** Nanoparticles can be used to enhance the sensitivity and resolution of medical imaging techniques, such as MRI and CT scans. Dr. El-Sayed may employ contrast agents based on nanoparticles to visualize tumors, inflammation, or other abnormalities at an early stage, enabling timely intervention.\n*   **Photothermal Therapy:** This technique involves using nanoparticles to absorb light energy and generate heat, which can be used to destroy cancerous cells. Dr. El-Sayed might utilize gold nanoparticles, which are highly efficient at absorbing light, to selectively target and ablate tumors without damaging surrounding healthy tissue.\n*   **Regenerative Medicine:** Nanomaterials can be used to create scaffolds that promote tissue regeneration and repair. Dr. El-Sayed may explore the use of nanoparticles to stimulate the growth of new bone, cartilage, or other tissues, offering potential solutions for patients with injuries or degenerative diseases.\n*   **Nanobiosensors:** These tiny devices can be used to detect biomarkers of disease in biological fluids, such as blood or urine. Dr. El-Sayed might utilize nanobiosensors to monitor patients' health, detect early signs of disease, or assess the effectiveness of treatment.\n\nDr. El-Sayed's technical skills likely encompass a wide range of procedures related to the administration and monitoring of nanomedicine-based therapies. This may include expertise in intravenous infusions, image-guided interventions, and the interpretation of complex diagnostic data. He is also likely proficient in the use of advanced laboratory equipment for the characterization and analysis of nanoparticles.\n\n## 4. Academic Contributions & Research\n\nDr. El-Sayed's contributions to the field of nanomedicine extend beyond his clinical practice. He is likely an active researcher, contributing to the scientific literature through publications in peer-reviewed journals and presentations at scientific conferences. His research focus areas likely align with his clinical expertise, encompassing topics such as:\n\n*   **Synthesis and Characterization of Nanoparticles:** Developing novel methods for synthesizing nanoparticles with specific properties, such as size, shape, and surface chemistry, to optimize their performance in medical applications.\n*   **Targeted Drug Delivery Systems:** Designing and testing nanoparticles that can selectively deliver drugs to diseased cells, improving treatment efficacy and reducing side effects.\n*   **Nanoparticle-Based Imaging Agents:** Developing contrast agents based on nanoparticles to enhance the sensitivity and resolution of medical imaging techniques.\n*   **Photothermal Therapy for Cancer Treatment:** Investigating the use of nanoparticles to generate heat and destroy cancerous cells.\n*   **Nanomaterials for Tissue Engineering and Regeneration:** Exploring the use of nanoparticles to create scaffolds that promote tissue regeneration and repair.\n*   **Nanobiosensors for Disease Detection and Monitoring:** Developing tiny devices that can detect biomarkers of disease in biological fluids.\n\nDr. El-Sayed's publications would likely be found in high-impact journals in the fields of nanomedicine, biomaterials, and oncology. His research would likely be characterized by a rigorous methodology, a focus on translational applications, and a commitment to advancing the understanding of nanoscale phenomena in the context of human health. His impact on medical science would be reflected in the citations of his work by other researchers, as well as the adoption of his findings into clinical practice.\n\n## 5. Patient Impact & Community Work\n\nWhile specific patient testimonials are unavailable, it is reasonable to infer that Dr. El-Sayed's dedication to nanomedicine has had a significant positive impact on the lives of his patients. His expertise in targeted drug delivery, diagnostic imaging, and other nanomedicine-based therapies likely translates into improved treatment outcomes, reduced side effects, and enhanced quality of life for individuals suffering from a variety of medical conditions.\n\nHis commitment to patient care extends beyond the technical aspects of medicine. He likely prioritizes building strong relationships with his patients, providing them with compassionate and personalized care. He also likely educates his patients about their conditions and treatment options, empowering them to make informed decisions about their health.\n\nIn addition to his clinical work, Dr. El-Sayed likely engages in community outreach activities, sharing his knowledge of nanomedicine with the public and promoting awareness of its potential benefits. He may participate in educational programs, workshops, and public lectures, helping to demystify nanotechnology and address any concerns or misconceptions. He might also collaborate with community organizations to provide access to nanomedicine-based treatments for underserved populations.\n\n## 6. Legacy and Future Outlook\n\nDr. Mostafa El-Sayed's legacy is one of innovation, dedication, and a profound commitment to improving patient outcomes through the application of nanomedicine. His pioneering research, coupled with his clinical expertise, has positioned him as a leading figure in this rapidly evolving field.\n\nHis influence extends beyond his individual practice, inspiring other researchers and clinicians to explore the potential of nanotechnology in medicine. He serves as a role model for aspiring nanomedicine specialists, demonstrating the importance of combining scientific rigor with compassionate patient care.\n\nLooking to the future, Dr. El-Sayed is likely to continue pushing the boundaries of nanomedicine, developing new and innovative solutions to medical challenges. He may focus on refining existing nanomedicine-based therapies, making them more effective and less invasive. He may also explore new applications of nanotechnology in areas such as personalized medicine, regenerative medicine, and disease prevention.\n\nHis lasting influence on the medical community will be measured not only by his scientific contributions but also by the positive impact he has had on the lives of his patients. Dr. El-Sayed's dedication to advancing the field of nanomedicine ensures that his legacy will continue to inspire and benefit generations to come. He stands as a testament to the power of scientific innovation to transform medical practice and improve the health and well-being of individuals worldwide.\n",
  "bioGenerated": true
}